These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17855636)

  • 1. Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism.
    Kawata T; Imanishi Y; Kobayashi K; Miki T; Arnold A; Inaba M; Nishizawa Y
    J Am Soc Nephrol; 2007 Oct; 18(10):2683-8. PubMed ID: 17855636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of the association between serum klotho and mortality among adults with rheumatoid arthritis in the USA.
    Che QC; Jia Q; Zhang XY; Sun SN; Zhang XJ; Shu Q
    Arthritis Res Ther; 2023 Aug; 25(1):149. PubMed ID: 37587536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updates in the chronic kidney disease-mineral bone disorder show the role of osteocytic proteins, a potential mechanism of the bone-Vascular paradox, a therapeutic target, and a biomarker.
    Williams MJ; White SC; Joseph Z; Hruska KA
    Front Physiol; 2023; 14():1120308. PubMed ID: 36776982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of FGF23 production and phosphate metabolism by bone-kidney interactions.
    Agoro R; White KE
    Nat Rev Nephrol; 2023 Mar; 19(3):185-193. PubMed ID: 36624273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of osteocytes in phosphate metabolism.
    Michigami T
    Front Endocrinol (Lausanne); 2022; 13():967774. PubMed ID: 35909535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid Hormone Regulates Circulating Levels of Sclerostin and FGF23 in a Primary Hyperparathyroidism Model.
    Nagata Y; Imanishi Y; Tateishi T; Miyaoka D; Kurajoh M; Arnold A; Emoto M
    J Endocr Soc; 2022 Apr; 6(4):bvac027. PubMed ID: 35284773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Expression Analysis of Cardiac Fibroblast Growth Factor 23 in Health and Pressure-induced Cardiac Hypertrophy.
    Eitner F; Richter B; Schwänen S; Szaroszyk M; Vogt I; Grund A; Thum T; Heineke J; Haffner D; Leifheit-Nestler M
    Front Cell Dev Biol; 2021; 9():791479. PubMed ID: 35118076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactic acid induces fibroblast growth factor 23 (FGF23) production in UMR106 osteoblast-like cells.
    Alber J; Föller M
    Mol Cell Biochem; 2022 Feb; 477(2):363-370. PubMed ID: 34731356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerostin antibody improves phosphate metabolism hormones, bone formation rates, and bone mass in adult Hyp mice.
    Carpenter KA; Davison R; Shakthivel S; Anderson KD; Ko FC; Ross RD
    Bone; 2022 Jan; 154():116201. PubMed ID: 34537437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The osteocyte as a signaling cell.
    Delgado-Calle J; Bellido T
    Physiol Rev; 2022 Jan; 102(1):379-410. PubMed ID: 34337974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rickets in Children: An Update.
    Gentile C; Chiarelli F
    Biomedicines; 2021 Jun; 9(7):. PubMed ID: 34199067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium.
    Laurent MR; De Schepper J; Trouet D; Godefroid N; Boros E; Heinrichs C; Bravenboer B; Velkeniers B; Lammens J; Harvengt P; Cavalier E; Kaux JF; Lombet J; De Waele K; Verroken C; van Hoeck K; Mortier GR; Levtchenko E; Vande Walle J
    Front Endocrinol (Lausanne); 2021; 12():641543. PubMed ID: 33815294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ap2s1 mutation causes hypercalcaemia in mice and impairs interaction between calcium-sensing receptor and adaptor protein-2.
    Hannan FM; Stevenson M; Bayliss AL; Stokes VJ; Stewart M; Kooblall KG; Gorvin CM; Codner G; Teboul L; Wells S; Thakker RV
    Hum Mol Genet; 2021 May; 30(10):880-892. PubMed ID: 33729479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher maternal parathyroid hormone concentration at delivery is not associated with smaller newborn size.
    Qamar H; Perumal N; Papp E; Gernand AD; Al Mahmud A; Roth DE
    Endocr Connect; 2021 Mar; 10(3):345-357. PubMed ID: 33640873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Serum Level of FGF23 and 1,25(OH)
    Hassani S; Afkhamizadeh M; Teimouri A; Najaf Najafi M; Vazifeh Mostaan L; Mohebbi M
    Int J Gen Med; 2020; 13():289-295. PubMed ID: 32606893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Vascular Calcification in Chronic Kidney Disease.
    Nelson AJ; Raggi P; Wolf M; Gold AM; Chertow GM; Roe MT
    JACC Basic Transl Sci; 2020 Apr; 5(4):398-412. PubMed ID: 32368697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memo1 gene expression in kidney and bone is unaffected by dietary mineral load and calciotropic hormones.
    Moor MB; Bonny O
    Physiol Rep; 2020 Apr; 8(7):e14410. PubMed ID: 32291966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF23 and Associated Disorders of Phosphate Wasting.
    Gohil A; Imel EA
    Pediatr Endocrinol Rev; 2019 Sep; 17(1):17-34. PubMed ID: 31599133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF23 at the crossroads of phosphate, iron economy and erythropoiesis.
    Edmonston D; Wolf M
    Nat Rev Nephrol; 2020 Jan; 16(1):7-19. PubMed ID: 31519999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the Concentration of Bone Metabolism Markers: Sclerostin and FGF-23 in Children with Idiopathic Nephrotic Syndrome Treated with Glucocorticosteroids.
    Pukajło-Marczyk A; Jakubowska A; Bargenda-Lange A; Kiliś-Pstrusińska K; Zwolińska D
    Dis Markers; 2019; 2019():9698367. PubMed ID: 31354894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.